• PHENFORMIN CHEMBL170988 Antineoplastic

    Alternate Names:

    Phenformin
    114-86-3
    β-Phenethybiguanide
    Fenformin
    DB00914
    FENORMIN
    PEDG
    PRESTWICK1_000179
    1-(DIAMINOMETHYLIDENE)-2-PHENETHYLGUANIDINE
    HSDB 3154
    DAP000206
    MELTROL
    CRONOFORMIN
    N'-BETA-PHENETHYLFORMAMIDINYLLIMINOUREA
    DIBIRAF
    W 32
    PHENETHYLDIGUANIDE
    CHEBI:382509
    FENFODURON
    PHENFORMINUM
    FENFORMINA
    151385
    PHENOFORMINE HYDROCHLORIDE
    PHENFORMIN [INN:BAN]
    PRESTWICK3_000179
    ZINC14768667
    BIGUANIDE, 1-PHENETHYL-
    CAS-834-28-6
    PHENFORMIN (BAN)
    LS-569
    GLUKOPOSTIN
    KBIO3_002871
    GLYPHEN
    KBIOSS_002397
    4-12-00-02472 (BEILSTEIN HANDBOOK REFERENCE)
    NCGC00016543-01
    EINECS 204-057-4
    BETA-PHENETHYLBIGUANIDE
    D08351
    PHENFORMINE HCL
    PRESTWICK2_000179
    BETA-PEBG
    PHENYLETHYLBIGUANIDE
    N'-BETA-FENETILFORMAMIDINILIMINOUREA
    SPBIO_001998
    UNII-DD5K7529CE
    FENFORMINA [INN-SPANISH]
    1-PHENETHYLBIGUANIDE
    KBIO2_002392
    CID8249
    RETARDO
    NCGC00016543-02
    DEBEONE
    AC1Q4YZM
    DB COMB
    AZUCAPS
    BRN 1977317
    KBIO2_007528
    PHENFORMIN (SEE ALSO PHENFORMIN HYDROCHLORIDE 834-28-6)
    DB-RETARD
    PHENFORMIX
    CMAP_000038
    MELTROL-50
    DEBINYL
    KBIO2_004960
    N-(2-PHENYLETHYL)IMIDODICARBONIMIDIC DIAMIDE
    IMIDODICARBONIMIDIC DIAMIDE, N-(2-PHENYLETHYL)-
    LENTOBETIC
    I14-13372
    MOLPORT-001-792-517
    NORMOGLUCINA
    8249
    AC1L1QL7
    BETA-PHENETHYBIGUANIDE
    PHENFORMINUM [INN-LATIN]
    PHENFORMINE [INN-FRENCH]
    C07673
    N'-BETA-FENETILFORMAMIDINILIMINOUREA [ITALIAN]
    FEGUANIDE
    KBIOGR_002392
    D BRETARD
    BPBIO1_000085
    N-PHENETHYLBIGUANIDE HYDROCHLORIDE
    DIBEIN
    DIABIS
    PRESTWICK0_000179
    DIPAR
    DBI MONOHYDROCHLORIDE
    DIBOTIN
    NCI-C01741
    PHENFORMINE
    BRD-K11399644-003-03-0
    BSPBIO_000077
    STK635703
    INSORAL
    CCRIS 500
    N-AMINO(IMINO)METHYL-N-PHENETHYLIMINOMETHANEDIAMINE(PHENFORMIN)
    N''''-[(E)-AMINO(IMINO)METHYL]-N-(2-PHENYLETHYL)GUANIDINE
    N-(2-PHENYLETHYL)IMIDODICARBONIMIDIC DIAMIDE(PHENFORMIN)
    N''''-{AMINO[(2-PHENYLETHYL)IMINO]METHYL}GUANIDINE
    1-(DIAMINOMETHYLIDENE)-2-(2-PHENYLETHYL)GUANIDINE
    1-(DIAMINOMETHYLENE)-2-(2-PHENYLETHYL)GUANIDINE
    ST45029292
    N-(2-PHENYLETHYL)DICARBONIMIDIC DIAMIDE #
    SMR004703510
    OR205497
    OR050893
    N'-.BETA.-PHENETHYLFORMAMIDINYLLIMINOUREA
    M819
    AN-43178
    NCGC00016543-08
    NCGC00016543-05
    NCGC00016543-04
    NCGC00016543-03
    TRA0068161
    MCULE-1254555434
    N'-.BETA.-FENETILFORMAMIDINILIMINOUREA
    AKOS005567415
    1-CARBAMIMIDOYL-3-PHENETHYL-GUANIDINE
    SBB072819
    BDBM50240908
    BBL010845
    ZINC5851063
    HMS3604G03
    SCHEMBL10325620
    DD5K7529CE
    MLS006011899
    SCHEMBL8424
    .BETA.-PHENETHYLBIGUANIDE
    MELTROL (SALT/MIX)
    .BETA.-PEBG
    DIPAR (SALT/MIX)
    AMINO{IMINO[(2-PHENYLETHYL)AMINO]METHYL}CARBOXAMIDINE
    PHENETHYLBIGUANIDE
    ICFJFFQQTFMIBG-UHFFFAOYSA-N
    CHEBI:8064
    N-PHENETHYLBIGUANIDE
    LS-190139
    24848280

    Drug Info:

    FDA Approval Approved before 1982
    Drug Class small molecule
    Drug Indications Hypoglycemic Agents
    Year of Approval approved before 1982
    Drug Class hypoglycemic agents
    Drug Categories physiological effects of drugs
    Drug Categories pharmacologic actions
    Drug Categories organic chemicals
    Drug Categories indoles
    Drug Categories hypoglycemic agents
    Drug Categories heterocyclic compounds, 2-ring
    Drug Categories heterocyclic compounds
    Drug Categories guanidines
    Drug Categories drugs used in diabetes
    Drug Categories cytochrome p-450 cyp2d6 substrates
    Drug Categories chemical actions and uses
    Drug Categories blood glucose lowering drugs, excl. insulins
    Drug Categories biguanides
    Drug Categories amidines
    Drug Categories alimentary tract and metabolism
    Drug Categories acids, heterocyclic
    Drug Groups withdrawn
    Drug Groups approved
    Drug Type small molecule
    (4 More Sources)